{"product_id":"electrocardiogram-in-clinical-medicine-isbn-9781118754559","title":"Electrocardiogram in Clinical Medicine","description":"\u003cp\u003e\u003cb\u003eOffers a guide for a complete understanding of the disease and conditions most frequently revealed in ECGs recorded in the acute, critical, and emergency care settings\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eElectrocardiogram in Clinical Medicine\u003c\/i\u003e offers an authoritative guide to ECG interpretation that contains a focus and perspective from each of the three primary areas of medical care: acute care, critical care and emergency care. It can be used as a companion with the book \u003ci\u003eECGs for the Emergency Physician I \u0026amp; II\u003c\/i\u003e (by Mattu and Brady) or as a stand-alone text. These three books can be described as a cumulative EGG reference for the medical provider who uses the electrocardiogram on a regular basis.   \u003c\/p\u003e \u003cp\u003e\u003ci\u003eElectrocardiogram in Clinical Medicine\u003c\/i\u003e includes sections on all primary areas of ECG interpretation and application as well as sections that highlight use, devices and strategies. The medical content covers acute coronary syndromes and all related issues, other diseases of the myocardium, morphologic syndromes, toxicology and paediatrics; dysrhythmias will also be covered in detail. This important resource:\u003c\/p\u003e \u003cp\u003e•    Goes beyond pattern recognition in ECGs to offer a real understanding of the clinical syndromes evidenced in ECGs and implications for treatment\u003c\/p\u003e \u003cp\u003e•    Covers the indications, advantages and pitfalls of the use of ECGs for diagnosis in all acute care settings, from EMS to ED to Critical Care\u003c\/p\u003e \u003cp\u003e•    Examines the ECG in toxic, metabolic and environmental presentations; critical information for acute care clinicians who need to be able to differentiate ODs, poisoning and other environmental causes from MI or other cardiac events\u003c\/p\u003e \u003cp\u003e•    Facilitates clinical decision-making \u003c\/p\u003e \u003cp\u003eWritten for practicing ER, general medicine, family practice, hospitalist and ICU physicians and medical students, \u003ci\u003eElectrocardiogram in Clinical Medicine\u003c\/i\u003e is an important book for the accurate interpretation of EGG results.\u003c\/p\u003e \u003cp\u003eList of Contributors xxi\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection I The ECG in Clinical Practice \u003c\/b\u003e\u003cb\u003e1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 The ECG in Clinical Medicine \u003c\/b\u003e\u003cb\u003e3\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eBrian Kessen and Kelly Williamson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 3\u003c\/p\u003e \u003cp\u003eThe ECG as a Clinical Tool 3\u003c\/p\u003e \u003cp\u003eClinical Presentations and the ECG 4\u003c\/p\u003e \u003cp\u003eChest Pain 4\u003c\/p\u003e \u003cp\u003eDyspnea 5\u003c\/p\u003e \u003cp\u003eSyncope 6\u003c\/p\u003e \u003cp\u003eToxicology 7\u003c\/p\u003e \u003cp\u003eElectrolyte Abnormalities 7\u003c\/p\u003e \u003cp\u003ePacemakers 10\u003c\/p\u003e \u003cp\u003eConclusion 10\u003c\/p\u003e \u003cp\u003eReferences 10\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 History of the Electrocardiogram \u003c\/b\u003e\u003cb\u003e13\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eTrale Permar and Kelly Williamson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eReferences 17\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection II ECG Changes in Myocardial Ischemia \u003c\/b\u003e\u003cb\u003e19\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 The Cardiac Action Potential and Changes in the Setting of Acute Coronary Syndrome: How Ischemia and Infarction Impacts the ECG \u003c\/b\u003e\u003cb\u003e21\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eKirsti A. Campbell and Michael J. Lipinski\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 21\u003c\/p\u003e \u003cp\u003eBasic Electrophysiology 21\u003c\/p\u003e \u003cp\u003eAction Potentials in Sodium-Dependent Depolarizers 21\u003c\/p\u003e \u003cp\u003eAction Potential in Calcium-Dependent Depolarizers 24\u003c\/p\u003e \u003cp\u003eAnatomy of the Electrical Conduction System 24\u003c\/p\u003e \u003cp\u003eBiochemical Impact of Ischemia 25\u003c\/p\u003e \u003cp\u003eST-Segment Deviation 25\u003c\/p\u003e \u003cp\u003eQRS Complex 30\u003c\/p\u003e \u003cp\u003eT Waves 31\u003c\/p\u003e \u003cp\u003eP Waves 31\u003c\/p\u003e \u003cp\u003eU Waves 34\u003c\/p\u003e \u003cp\u003eMyocardial Ischemia: Causes Other than Acute Coronary Syndrome 34\u003c\/p\u003e \u003cp\u003eConclusion 34\u003c\/p\u003e \u003cp\u003eReferences 36\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Ischemic Electrocardiographic Changes and Correlation with Regions of the Myocardium \u003c\/b\u003e\u003cb\u003e37\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eThibault Lhermusier and Michael J. Lipinski\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 37\u003c\/p\u003e \u003cp\u003eCoronary Anatomy 37\u003c\/p\u003e \u003cp\u003eDefinitions of STEMI and Non-ST Elevation ACS 38\u003c\/p\u003e \u003cp\u003eLeft Main Coronary Ischemia 39\u003c\/p\u003e \u003cp\u003eAnterior STEMI 40\u003c\/p\u003e \u003cp\u003eWellens Syndrome 40\u003c\/p\u003e \u003cp\u003eInferior STEMI 41\u003c\/p\u003e \u003cp\u003eRight Ventricular Infarction 41\u003c\/p\u003e \u003cp\u003eLateral STEMI 44\u003c\/p\u003e \u003cp\u003ePosterior STEMI 44\u003c\/p\u003e \u003cp\u003eConduction Abnormalities in the Setting of Ischemia 46\u003c\/p\u003e \u003cp\u003eAneurysm of the Left Ventricle 49\u003c\/p\u003e \u003cp\u003eECG in Pharmacological and Mechanical Reperfusion 49\u003c\/p\u003e \u003cp\u003eConclusion 50\u003c\/p\u003e \u003cp\u003eReferences 50\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 STEMI Mimics \u003c\/b\u003e\u003cb\u003e53\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePeter M. Pollak\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 53\u003c\/p\u003e \u003cp\u003eMyocarditis and Myopericarditis 53\u003c\/p\u003e \u003cp\u003eEarly Repolarization 55\u003c\/p\u003e \u003cp\u003eLeft Ventricular Hypertrophy 57\u003c\/p\u003e \u003cp\u003ePrior Infarction and Ventricular Aneurysm 58\u003c\/p\u003e \u003cp\u003eVasospasm (Prinzmetal or Variant Angina) 58\u003c\/p\u003e \u003cp\u003eApical Ballooning Syndrome (Takotsubo Cardiomyopathy) 61\u003c\/p\u003e \u003cp\u003eBrugada Pattern and Idiopathic Ventricular Fibrillation 62\u003c\/p\u003e \u003cp\u003eHyperkalemia 62\u003c\/p\u003e \u003cp\u003ePost-Cardioversion\/Shock 62\u003c\/p\u003e \u003cp\u003eHypothermia and Osborn Waves 62\u003c\/p\u003e \u003cp\u003ePulmonary Embolism 63\u003c\/p\u003e \u003cp\u003eOther Causes of ST Elevation 63\u003c\/p\u003e \u003cp\u003eConclusion 65\u003c\/p\u003e \u003cp\u003eReferences 65\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Confounders of ST\u003c\/b\u003e\u003cb\u003e‐Elevation Myocardial Infarction 69\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAmy West Pollak\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 69\u003c\/p\u003e \u003cp\u003eLeft Bundle Branch Block 69\u003c\/p\u003e \u003cp\u003eLBBB and Ischemic Heart Disease 69\u003c\/p\u003e \u003cp\u003eLeft Ventricular Hypertrophy 71\u003c\/p\u003e \u003cp\u003eVentricular Paced Rhythm 71\u003c\/p\u003e \u003cp\u003eRight Bundle Branch Block (RBBB) 73\u003c\/p\u003e \u003cp\u003eReferences 73\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 The Prognostic Value of the Electrocardiogram in Acute Coronary Syndromes \u003c\/b\u003e\u003cb\u003e75\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eBenjamin Shepple and Robert Gibson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 75\u003c\/p\u003e \u003cp\u003eThe ECG in Acute Coronary Syndromes 75\u003c\/p\u003e \u003cp\u003eST Elevation Myocardial Infarction (STEMI) 75\u003c\/p\u003e \u003cp\u003eThe ECG during Myocardial Injury 76\u003c\/p\u003e \u003cp\u003eThe ECG in Response to Therapy 80\u003c\/p\u003e \u003cp\u003eECG after Completion of Infarction 81\u003c\/p\u003e \u003cp\u003eUA\/NSTEMI 83\u003c\/p\u003e \u003cp\u003eST-Segment Depression 83\u003c\/p\u003e \u003cp\u003eT-Wave Inversions 84\u003c\/p\u003e \u003cp\u003eInitial Normal ECG 86\u003c\/p\u003e \u003cp\u003eArrhythmia and Conduction Disease 86\u003c\/p\u003e \u003cp\u003eVentricular Arrhythmias 86\u003c\/p\u003e \u003cp\u003ePremature Ventricular Contractions 87\u003c\/p\u003e \u003cp\u003eVentricular Tachycardia 87\u003c\/p\u003e \u003cp\u003eVentricular Fibrillation 87\u003c\/p\u003e \u003cp\u003eSupraventricular Tachycardia 89\u003c\/p\u003e \u003cp\u003eAV Conduction Delay and Heart Block 90\u003c\/p\u003e \u003cp\u003eProlonged QTc Interval 91\u003c\/p\u003e \u003cp\u003eConclusion 92\u003c\/p\u003e \u003cp\u003eReferences 92\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 ECG Tools: Alternate Lead Placement, Serial ECGs, and ECG Monitoring \u003c\/b\u003e\u003cb\u003e97\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAugustus E. Mealor, Yasir Akhtar, and Michael Ragosta\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 97\u003c\/p\u003e \u003cp\u003eRight-Sided Leads 97\u003c\/p\u003e \u003cp\u003ePosterior ECG 99\u003c\/p\u003e \u003cp\u003eSerial ECG Monitoring 101\u003c\/p\u003e \u003cp\u003eSTM-ECG 101\u003c\/p\u003e \u003cp\u003eSerial ECG Monitoring 101\u003c\/p\u003e \u003cp\u003eReferences 105\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Electrocardiographic Changes of Ischemia during Stress Testing \u003c\/b\u003e\u003cb\u003e107\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMichael J. Lipinski and Victor F. Froelicher\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 107\u003c\/p\u003e \u003cp\u003eExercise Physiology 108\u003c\/p\u003e \u003cp\u003eNormal ECG Changes with Exercise 108\u003c\/p\u003e \u003cp\u003eECG Changes with Ischemia 109\u003c\/p\u003e \u003cp\u003eWomen 114\u003c\/p\u003e \u003cp\u003eDiagnostic Scores 114\u003c\/p\u003e \u003cp\u003eTermination of Exercise Testing 114\u003c\/p\u003e \u003cp\u003eExercise Testing and Acute Coronary Syndromes 117\u003c\/p\u003e \u003cp\u003eExercise Testing after Myocardial Infarction 117\u003c\/p\u003e \u003cp\u003eRecommended Reading 120\u003c\/p\u003e \u003cp\u003eConclusions 120\u003c\/p\u003e \u003cp\u003eReferences 120\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection III The Dysrhythmic ECG \u003c\/b\u003e\u003cb\u003e123\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Bradycardia \u003c\/b\u003e\u003cb\u003e125\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAndrew E. Darby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 125\u003c\/p\u003e \u003cp\u003eAbnormalities of Sinus Node Function 125\u003c\/p\u003e \u003cp\u003eAbnormalities of Atrioventricular Nodal Conduction 126\u003c\/p\u003e \u003cp\u003eIndications for Cardiac Pacing 131\u003c\/p\u003e \u003cp\u003eConclusions 131\u003c\/p\u003e \u003cp\u003eReferences 132\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Atrioventricular (AV) Block \u003c\/b\u003e\u003cb\u003e133\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMark Marinescu and Andrew E. Darby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eFirst-Degree AV Block 133\u003c\/p\u003e \u003cp\u003eSecond-Degree AV Block 133\u003c\/p\u003e \u003cp\u003eThird-Degree AV Block 137\u003c\/p\u003e \u003cp\u003eIndications for Permanent Pacing 137\u003c\/p\u003e \u003cp\u003eConclusions 138\u003c\/p\u003e \u003cp\u003eReferences 138\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 The Dysrhythmic ECG: Intraventricular Block \u003c\/b\u003e\u003cb\u003e141\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAndrew E. Darby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 141\u003c\/p\u003e \u003cp\u003eAnatomy and Electrophysiology 141\u003c\/p\u003e \u003cp\u003eRight Bundle Branch Block 141\u003c\/p\u003e \u003cp\u003eLeft Bundle Branch Block 143\u003c\/p\u003e \u003cp\u003eNonspecific Intraventricular Conduction Delay 145\u003c\/p\u003e \u003cp\u003eFascicular Block 145\u003c\/p\u003e \u003cp\u003eReferences 146\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Narrow QRS Complex Tachycardia \u003c\/b\u003e\u003cb\u003e149\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAugustus E. Mealor and Andrew E. Darby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 149\u003c\/p\u003e \u003cp\u003eApproach to the ECG Diagnosis of NCT 150\u003c\/p\u003e \u003cp\u003eThe Regular Narrow Complex Tachycardias 151\u003c\/p\u003e \u003cp\u003eParoxysmal Supraventricular Tachycardia 154\u003c\/p\u003e \u003cp\u003eThe Irregular Narrow Complex Tachycardias 158\u003c\/p\u003e \u003cp\u003eReferences 160\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Wide QRS Complex Tachycardia \u003c\/b\u003e\u003cb\u003e161\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAndrew E. Darby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eVentricular Tachycardia 161\u003c\/p\u003e \u003cp\u003eVentricular Paced Rhythm 164\u003c\/p\u003e \u003cp\u003eDiagnosis of Wide QRS Complex Tachycardia by Electrocardiogram 166\u003c\/p\u003e \u003cp\u003eConclusions 167\u003c\/p\u003e \u003cp\u003eReferences 167\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Non-Sinus Rhythms with Normal Rates \u003c\/b\u003e\u003cb\u003e169\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eWill Dresen and Andrew E. Darby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 169\u003c\/p\u003e \u003cp\u003eEctopic Atrial Rhythm 169\u003c\/p\u003e \u003cp\u003eAccelerated Idioventricular Rhythm (AIVR) 172\u003c\/p\u003e \u003cp\u003eConclusions 172\u003c\/p\u003e \u003cp\u003eReferences 172\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Rhythms of Cardiac Arrest \u003c\/b\u003e\u003cb\u003e173\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eErich Kiehl and Andrew E. Darby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 173\u003c\/p\u003e \u003cp\u003eTorsade de Pointes 174\u003c\/p\u003e \u003cp\u003ePreexcited Atrial Fibrillation 174\u003c\/p\u003e \u003cp\u003ePulseless Electrical Activity 177\u003c\/p\u003e \u003cp\u003eConclusions 179\u003c\/p\u003e \u003cp\u003eReferences 179\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Premature Atrial and Ventricular Complexes \u003c\/b\u003e\u003cb\u003e181\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAdrián I. Löffler and Andrew E. Darby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePremature Atrial Contractions 181\u003c\/p\u003e \u003cp\u003ePremature Ventricular Contractions 184\u003c\/p\u003e \u003cp\u003eReferences 186\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Nontraditional Rhythm Disorders: Dysrhythmias Related to Metabolic and Toxicologic Conditions \u003c\/b\u003e\u003cb\u003e187\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAndrew E. Darby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 187\u003c\/p\u003e \u003cp\u003eAntiarrhythmic Drug Toxicity 188\u003c\/p\u003e \u003cp\u003eTricyclic Antidepressant Toxicity 190\u003c\/p\u003e \u003cp\u003eConclusions 191\u003c\/p\u003e \u003cp\u003eReferences 192\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Dysrhythmia-Related Syndromes \u003c\/b\u003e\u003cb\u003e193\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMichele Murphy and Andrew E. Darby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 193\u003c\/p\u003e \u003cp\u003eDysrhythmia-Related Syndromes – Primary Electrical Abnormalities 193\u003c\/p\u003e \u003cp\u003eWolff-Parkinson-White Syndrome 193\u003c\/p\u003e \u003cp\u003eDysrhythmia-Related Syndromes – Primary Cardiac Structural Conditions 197\u003c\/p\u003e \u003cp\u003eConclusions 199\u003c\/p\u003e \u003cp\u003eReferences 200\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection IV The ECG in Cardinal Presentations and Scenarios \u003c\/b\u003e\u003cb\u003e201\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 The Patient with Cardiac Arrest \u003c\/b\u003e\u003cb\u003e203\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMichael Cirone, Mitchell Lorenz, and Karis Tekwani\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 203\u003c\/p\u003e \u003cp\u003eVentricular Fibrillation 203\u003c\/p\u003e \u003cp\u003ePulseless Ventricular Tachycardia 203\u003c\/p\u003e \u003cp\u003eAsystole 205\u003c\/p\u003e \u003cp\u003ePulseless Electrical Activity 205\u003c\/p\u003e \u003cp\u003eConclusion 206\u003c\/p\u003e \u003cp\u003eReferences 206\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 The Patient with Chest Pain \u003c\/b\u003e\u003cb\u003e207\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePaul Basel, Lane Thaut, and Nathan Olson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 207\u003c\/p\u003e \u003cp\u003eAcute Coronary Syndrome 207\u003c\/p\u003e \u003cp\u003ePericarditis 213\u003c\/p\u003e \u003cp\u003eReferences 215\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 The Patient with Dyspnea \u003c\/b\u003e\u003cb\u003e219\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAdriana Segura Olson, Anders Messersmith, and Matthew Robinson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 219\u003c\/p\u003e \u003cp\u003ePulmonary Embolism 219\u003c\/p\u003e \u003cp\u003eCor Pulmonale 220\u003c\/p\u003e \u003cp\u003eCardiomyopathy 220\u003c\/p\u003e \u003cp\u003eCongestive Heart Failure 223\u003c\/p\u003e \u003cp\u003ePneumothorax 223\u003c\/p\u003e \u003cp\u003eASTHMA\/COPD 224\u003c\/p\u003e \u003cp\u003eAnaphylaxis\/Kounis Syndrome 225\u003c\/p\u003e \u003cp\u003eMetabolic 226\u003c\/p\u003e \u003cp\u003eSummary 227\u003c\/p\u003e \u003cp\u003eReferences 227\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 The Patient with Palpitations\/Syncope \u003c\/b\u003e\u003cb\u003e229\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eNatasha Wheaton, Emma Nash, and Jeffrey Brown\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eSupraventricular Tachycardia 229\u003c\/p\u003e \u003cp\u003eAtrial Fibrillation 229\u003c\/p\u003e \u003cp\u003eMultifocal Atrial Tachycardia 230\u003c\/p\u003e \u003cp\u003eConduction Blocks 232\u003c\/p\u003e \u003cp\u003eBrugada Syndrome 233\u003c\/p\u003e \u003cp\u003eHypertrophic Cardiomyopathy 234\u003c\/p\u003e \u003cp\u003eWolf-Parkinson-White Syndrome 234\u003c\/p\u003e \u003cp\u003eLong QT Syndrome 236\u003c\/p\u003e \u003cp\u003eArrhythmogenic Right Ventricular Dysplasia 237\u003c\/p\u003e \u003cp\u003eReferences 237\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 The Patient with Preoperative Evaluation \u003c\/b\u003e\u003cb\u003e239\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSarah Chuzi, Jane Wilcox, and Lisa B. Van Wagner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 239\u003c\/p\u003e \u003cp\u003eIndications 239\u003c\/p\u003e \u003cp\u003eCommon ECG Abnormalities 239\u003c\/p\u003e \u003cp\u003eNonspecific ST-T Changes 244\u003c\/p\u003e \u003cp\u003ePathologic Q Waves 244\u003c\/p\u003e \u003cp\u003eQT\/QTc Prolongation 245\u003c\/p\u003e \u003cp\u003eConclusion 245\u003c\/p\u003e \u003cp\u003eReferences 246\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 The Patient in Shock \u003c\/b\u003e\u003cb\u003e249\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMeagan R. Hunt and Nicholas D. Hartman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 249\u003c\/p\u003e \u003cp\u003eCardiogenic Shock 249\u003c\/p\u003e \u003cp\u003eObstructive Shock 252\u003c\/p\u003e \u003cp\u003eDistributive Shock 252\u003c\/p\u003e \u003cp\u003eHypovolemic Shock 262\u003c\/p\u003e \u003cp\u003eSummary 262\u003c\/p\u003e \u003cp\u003eReferences 263\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 The Patient with Overdose \u003c\/b\u003e\u003cb\u003e265\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAshley Pastore and Andrea Carlson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 265\u003c\/p\u003e \u003cp\u003eApproach to the ECG in the Poisoned Patient 265\u003c\/p\u003e \u003cp\u003eClassic Toxicology ECGs 267\u003c\/p\u003e \u003cp\u003eDrug-Induced SVT 268\u003c\/p\u003e \u003cp\u003eBrugada Pattern 268\u003c\/p\u003e \u003cp\u003eTricyclics Antidepressants 268\u003c\/p\u003e \u003cp\u003eCalcium Channel Blockers 272\u003c\/p\u003e \u003cp\u003eConclusion 273\u003c\/p\u003e \u003cp\u003eReferences 274\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection V The ECG in Poison, Electrolyte, Metabolic and Environmental Emergencies \u003c\/b\u003e\u003cb\u003e275\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 ECG Diagnosis and Management of the Poisoned Patient \u003c\/b\u003e\u003cb\u003e277\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eWilliam F. Rushton and Christopher P. Holstege\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 277\u003c\/p\u003e \u003cp\u003eCardiac Action Potential 277\u003c\/p\u003e \u003cp\u003eTachycardia in the Poisoned Patient 277\u003c\/p\u003e \u003cp\u003eBradycardia 278\u003c\/p\u003e \u003cp\u003eQRS Prolongation 279\u003c\/p\u003e \u003cp\u003eQT Prolongation 282\u003c\/p\u003e \u003cp\u003eConclusion 283\u003c\/p\u003e \u003cp\u003eReferences 284\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 The Use of the ECG in the Poisoned Patient: The “Rule-out Ingestion” Strategy \u003c\/b\u003e\u003cb\u003e287\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eHeather A. Borek and Lewis S. Hardison\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 287\u003c\/p\u003e \u003cp\u003eBackground 287\u003c\/p\u003e \u003cp\u003eRate 287\u003c\/p\u003e \u003cp\u003eRhythm 289\u003c\/p\u003e \u003cp\u003eMorphology of the Cardiac Action Potential and the ECG 290\u003c\/p\u003e \u003cp\u003eQRS Interval Prolongation 290\u003c\/p\u003e \u003cp\u003eQTc Interval Prolongation 292\u003c\/p\u003e \u003cp\u003eTiming 293\u003c\/p\u003e \u003cp\u003eThe Undifferentiated Patient 294\u003c\/p\u003e \u003cp\u003eConclusion 294\u003c\/p\u003e \u003cp\u003eReferences 295\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 The ECG and Electrolyte Abnormalities \u003c\/b\u003e\u003cb\u003e297\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJustin Rizer, Joshua D. King, and Nathan P. Charlton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 297\u003c\/p\u003e \u003cp\u003eCalcium 297\u003c\/p\u003e \u003cp\u003eHypocalcemia 297\u003c\/p\u003e \u003cp\u003eHypercalcemia 298\u003c\/p\u003e \u003cp\u003eMagnesium 298\u003c\/p\u003e \u003cp\u003eHypomagnesemia 299\u003c\/p\u003e \u003cp\u003ePotassium 300\u003c\/p\u003e \u003cp\u003eHyperkalemia 300\u003c\/p\u003e \u003cp\u003eHypokalemia 303\u003c\/p\u003e \u003cp\u003eReferences 305\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 The ECG and Metabolic Abnormalities \u003c\/b\u003e\u003cb\u003e307\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eGeorge F. Glass, Amita Sudhir, and Amit Anil Kumar Pandit\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction Metabolic Disturbances and the ECG 307\u003c\/p\u003e \u003cp\u003eECG Findings During Acute Complications of Diabetes Mellitus 307\u003c\/p\u003e \u003cp\u003eDisturbances Due to Alterations of pH 309\u003c\/p\u003e \u003cp\u003eOther Metabolic Conditions 311\u003c\/p\u003e \u003cp\u003eReferences 311\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 The ECG in Environmental Urgencies and Emergencies \u003c\/b\u003e\u003cb\u003e315\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eHeather T. Lounsbury and Seth O. Althoff\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 315\u003c\/p\u003e \u003cp\u003eHypothermia 315\u003c\/p\u003e \u003cp\u003eLightning Strikes 319\u003c\/p\u003e \u003cp\u003eUnderwater Submersion 321\u003c\/p\u003e \u003cp\u003eHeat Stroke 322\u003c\/p\u003e \u003cp\u003eConclusion 324\u003c\/p\u003e \u003cp\u003eReferences 324\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection VI The ECG in Special Inpatient Groups \u003c\/b\u003e\u003cb\u003e327\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 The ECG-Monitored Patient \u003c\/b\u003e\u003cb\u003e329\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eFeras Khan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 329\u003c\/p\u003e \u003cp\u003eClinical Scenarios Requiring Telemetry\/Electrocardiographic Monitoring 329\u003c\/p\u003e \u003cp\u003eConclusion 332\u003c\/p\u003e \u003cp\u003eReferences 334\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Electrocardiography in the Operating Room \u003c\/b\u003e\u003cb\u003e335\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eFeras Khan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 335\u003c\/p\u003e \u003cp\u003eTypes of Monitoring 335\u003c\/p\u003e \u003cp\u003eRisks for Arrhythmias in the OR 335\u003c\/p\u003e \u003cp\u003ePostoperative Electrocardiographic Abnormalities 335\u003c\/p\u003e \u003cp\u003eInitial Management and ECG Evaluation 335\u003c\/p\u003e \u003cp\u003eTypes of Arrhythmias 336\u003c\/p\u003e \u003cp\u003eSpecific Clinical Conditions 341\u003c\/p\u003e \u003cp\u003eConclusion 342\u003c\/p\u003e \u003cp\u003eReferences 343\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 ECG in the ICU Patient: Identification and Treatment of Arrhythmias in the Intensive Care Unit \u003c\/b\u003e\u003cb\u003e345\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eFeras Khan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 345\u003c\/p\u003e \u003cp\u003eCommon Dysrhythmias in the ICU 345\u003c\/p\u003e \u003cp\u003eOther Common Electrocardiographic Findings 352\u003c\/p\u003e \u003cp\u003eThe Effect of Vasopressors on Cardiac Conduction 352\u003c\/p\u003e \u003cp\u003eConsequences of Anti-Arrhythmic Medications 353\u003c\/p\u003e \u003cp\u003eArrhythmias Induced by Central Line Placement 354\u003c\/p\u003e \u003cp\u003eSpecific Clinical Conditions 354\u003c\/p\u003e \u003cp\u003eConclusion 357\u003c\/p\u003e \u003cp\u003eReferences 357\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 The ECG in Patients with Implanted Cardiac Devices \u003c\/b\u003e\u003cb\u003e359\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAli Farzad, Benjamin J. Lawner, and Tu Carol Nguyen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eBasics of Pacemakers 359\u003c\/p\u003e \u003cp\u003eElectrocardiographic Findings in Normally Functioning Pacemakers 360\u003c\/p\u003e \u003cp\u003eElectrocardiographic Findings in Abnormally Functioning Pacemakers 361\u003c\/p\u003e \u003cp\u003eKey Points: Electrocardiographic Clues to Pacemaker Malfunction 368\u003c\/p\u003e \u003cp\u003eElectrocardiographic Diagnosis of Acute Myocardial Infarction in the Presence of a Paced Rhythm 368\u003c\/p\u003e \u003cp\u003eBasics of the Implantable Cardioverter Defibrillator 370\u003c\/p\u003e \u003cp\u003eElectrocardiographic Findings after Defibrillation 370\u003c\/p\u003e \u003cp\u003eBasics of Left Ventricular Assist Devices 371\u003c\/p\u003e \u003cp\u003eReferences 375\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Electrocardiographic Manifestations of Cardiac Transplantation \u003c\/b\u003e\u003cb\u003e377\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSemhar Tewelde\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 377\u003c\/p\u003e \u003cp\u003eCardiac Transplantation 377\u003c\/p\u003e \u003cp\u003eConclusion 80\u003c\/p\u003e \u003cp\u003eKey Points 380\u003c\/p\u003e \u003cp\u003eReferences 380\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection VII Electrocardiographic Differential Diagnosis \u003c\/b\u003e\u003cb\u003e383\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Abnormalities of the P Wave and PR Interval \u003c\/b\u003e\u003cb\u003e385\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMatthew Borloz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eThe Normal P Wave 385\u003c\/p\u003e \u003cp\u003eThe Abnormal P Wave 385\u003c\/p\u003e \u003cp\u003eThe Normal PR Interval 387\u003c\/p\u003e \u003cp\u003eThe Abnormal PR Interval 387\u003c\/p\u003e \u003cp\u003eConclusion 395\u003c\/p\u003e \u003cp\u003eReferences 395\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Differential Diagnosis of QRS Complex Abnormalities \u003c\/b\u003e\u003cb\u003e397\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMatthew Wilson, Michael Ybarra, and Munish Goyal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eQRS Complex Abnormalities 397\u003c\/p\u003e \u003cp\u003eThe Large QRS Complex 397\u003c\/p\u003e \u003cp\u003eThe Small QRS Complex 398\u003c\/p\u003e \u003cp\u003eThe Wide QRS Complex 399\u003c\/p\u003e \u003cp\u003eReferences 405\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Differential Diagnosis of ST Segment Changes \u003c\/b\u003e\u003cb\u003e407\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eKorin Hudson and Norine McGrath\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 407\u003c\/p\u003e \u003cp\u003eDescribing ST-Segment Changes 407\u003c\/p\u003e \u003cp\u003eAcute Coronary Syndrome and Related ST Segment Deviation 408\u003c\/p\u003e \u003cp\u003eNonischemic Causes of ST-Segment Changes 412\u003c\/p\u003e \u003cp\u003eBenign Early Repolarization 414\u003c\/p\u003e \u003cp\u003eAcute Myocarditis\/Pericarditis 415\u003c\/p\u003e \u003cp\u003eVentricular Aneurysm 416\u003c\/p\u003e \u003cp\u003eDigitalis 416\u003c\/p\u003e \u003cp\u003eHypothermia 417\u003c\/p\u003e \u003cp\u003eHyperkalemia 417\u003c\/p\u003e \u003cp\u003eBrugada Syndrome 417\u003c\/p\u003e \u003cp\u003eTachycardia-Related STD 418\u003c\/p\u003e \u003cp\u003eCNS Injury 418\u003c\/p\u003e \u003cp\u003eOther Causes 418\u003c\/p\u003e \u003cp\u003eReferences 419\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 ECG Differential Diagnosis of T Wave and QT Interval Abnormalities \u003c\/b\u003e\u003cb\u003e421\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSanjay Shewakramani and Kari Gorder\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eThe T Wave 421\u003c\/p\u003e \u003cp\u003eProminent T Waves 421\u003c\/p\u003e \u003cp\u003eBenign Early Repolarization 422\u003c\/p\u003e \u003cp\u003eT-Wave Inversions 422\u003c\/p\u003e \u003cp\u003eThe QT Interval 427\u003c\/p\u003e \u003cp\u003eQT Prolongation 428\u003c\/p\u003e \u003cp\u003eCongenital Long QT Syndrome 429\u003c\/p\u003e \u003cp\u003eShort QT Interval 429\u003c\/p\u003e \u003cp\u003eCongenital Short QT Syndrome 429\u003c\/p\u003e \u003cp\u003eReferences 429\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Bradycardia \u003c\/b\u003e\u003cb\u003e433\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eB. Elizabeth Delasobera and Tress Goodwin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eBradycardia Basics 433\u003c\/p\u003e \u003cp\u003eBradycardia Rhythms 433\u003c\/p\u003e \u003cp\u003eRhythms That Can Be Slow 434\u003c\/p\u003e \u003cp\u003eSlow Atrial Fibrillation 435\u003c\/p\u003e \u003cp\u003eSlow Atrial Flutter 437\u003c\/p\u003e \u003cp\u003eAV Blocks 437\u003c\/p\u003e \u003cp\u003eFirst-Degree AV Block 438\u003c\/p\u003e \u003cp\u003eSecond-Degree AV Block: Mobitz Type 1 (Wenckebach) 438\u003c\/p\u003e \u003cp\u003eSecond-Degree AV Block: Mobitz Type 2 438\u003c\/p\u003e \u003cp\u003eThird-Degree or Complete Heart Block 439\u003c\/p\u003e \u003cp\u003eConclusion 439\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Rhythms Presenting with Normal Rate \u003c\/b\u003e\u003cb\u003e441\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRobert Katzer and Janet Smereck\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eDefinitions and Clinical Considerations 441\u003c\/p\u003e \u003cp\u003eRegular Rhythms 441\u003c\/p\u003e \u003cp\u003eIrregular Rhythms 442\u003c\/p\u003e \u003cp\u003eReferences 447\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Narrow Complex Tachycardia \u003c\/b\u003e\u003cb\u003e449\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDavid J. Carlberg and Rahul Bhat\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 449\u003c\/p\u003e \u003cp\u003eMechanisms for NCTs 449\u003c\/p\u003e \u003cp\u003eApproach to NCT 450\u003c\/p\u003e \u003cp\u003eSinus Node Tachycardias 453\u003c\/p\u003e \u003cp\u003eAtrial Tachycardias 453\u003c\/p\u003e \u003cp\u003eReentrant Tachycardia Involving the AV Node 457\u003c\/p\u003e \u003cp\u003eJunctional Tachycardia 459\u003c\/p\u003e \u003cp\u003eConclusions 459\u003c\/p\u003e \u003cp\u003eReferences 460\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Wide Complex Tachycardia \u003c\/b\u003e\u003cb\u003e461\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eScott Young and Rachel Villacorta Lyew\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction to Wide Complex Tachycardia 461\u003c\/p\u003e \u003cp\u003eMonomorphic WCT 461\u003c\/p\u003e \u003cp\u003ePolymorphic WCTs 468\u003c\/p\u003e \u003cp\u003eReferences 470\u003c\/p\u003e \u003cp\u003eIndex 473\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eWilliam J. Brady, MD\u003c\/b\u003e, is Professor of Emergency Medicine and Medicine, University of Virginia, Charlottesville, VA, USA. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eMichael J. Lipinski, MD, PhD,\u003c\/b\u003e is Cardiovascular Associates of Charlottesville, Charlottesville, VA, USA. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eAndrew E. Darby, MD, FHRS,\u003c\/b\u003e is Associate Professor of Cardiovascular Medicine, University of Virginia Health System, Charlottesville, VA, USA. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eMichael C. Bond, MD, FACEP, FAAEM,\u003c\/b\u003e is Associate Professor of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eNathan P. Charlton, MD,\u003c\/b\u003e is Associate Professor of Emergency Medicine, Division of Medical Toxicology, University of Virginia, Charlottesville, VA, USA. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eKorin Hudson, MD,\u003c\/b\u003e is Associate Professor of Emergency Medicine, MedStar Georgetown University Hospital, Georgetown University School of Medicine, Washington, DC, USA. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eKelly Williamson, MD,\u003c\/b\u003e is Assistant Residency Program Director, Advocate Christ Medical Center Emergency Medicine Residency; and is Clinical Associate Professor of Emergency Medicine, University of Illinois at Chicago, Chicago, IL, USA.   \u003c\/p\u003e\u003cp\u003e\u003cb\u003eOffers a guide for a complete understanding of the disease and conditions most frequently revealed in ECGs recorded in the acute, critical, and emergency care settings\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e\u003ci\u003eElectrocardiogram in Clinical Medicine\u003c\/i\u003e offers an authoritative guide to ECG interpretation that contains a focus and perspective from each of the three primary areas of medical care: acute care, critical care and emergency care. It can be used as a companion with the book \u003ci\u003eECGs for the Emergency Physician I \u0026amp; II\u003c\/i\u003e (by Mattu and Brady) or as a stand-alone text. These three books can be described as a cumulative EGG reference for the medical provider who uses the electrocardiogram on a regular basis. \u003c\/p\u003e\u003cp\u003e\u003ci\u003eElectrocardiogram in Clinical Medicine\u003c\/i\u003e includes sections on all primary areas of ECG interpretation and application as well as sections that highlight use, devices and strategies. The medical content covers acute coronary syndromes and all related issues. Other diseases of the myocardium, morphologic syndromes, toxicology and paediatrics and dysrhythmias will also be covered in detail. This important resource: \u003c\/p\u003e\u003cul\u003e \u003cli\u003egoes beyond pattern recognition in ECGs to offer a real understanding of the clinical syndromes evidenced in ECGs and implications for treatment\u003c\/li\u003e \u003cli\u003ecovers the indications, advantages and pitfalls of the use of ECGs for diagnosis in all acute care settings, from EMS to ED to Critical Care\u003c\/li\u003e \u003cli\u003eexamines the ECG in toxic, metabolic and environmental presentations; critical information for acute care clinicians who need to be able to differentiate ODs, poisoning and other environmental causes from MI or other cardiac events\u003c\/li\u003e \u003cli\u003efacilitates clinical decision-making??\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eWritten for practicing ER, general medicine, family practice, hospitalist and ICU physicians and medical students, \u003ci\u003eElectrocardiogram in Clinical Medicine\u003c\/i\u003e is an important book for the accurate interpretation of EGG results.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989112963301,"sku":"NP9781118754559","price":74.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118754559.jpg?v=1761782848","url":"https:\/\/k12savings.com\/es\/products\/electrocardiogram-in-clinical-medicine-isbn-9781118754559","provider":"K12savings","version":"1.0","type":"link"}